Publication:

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis

Date

Date

Date
2019
Journal Article
Published version

Citations

Citation copied

Sandborn, W. J., Cyrille, M., Hansen, M. B., Feagan, B. G., Loftus, E. V., Rogler, G., Vermeire, S., Cruz, M. L., Yang, J., Boedigheimer, M. J., Abuqayyas, L., Evangelista, C. M., Sullivan, B. A., & Reinisch, W. (2019). Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis. Gastroenterology, 156, 946-957.e18. https://doi.org/10.1053/j.gastro.2018.11.035

Abstract

Abstract

Abstract

BACKGROUND & AIMS: The α4β7 integrin is a validated target in inflammatory bowel disease. This randomized, phase 2b, placebo-controlled, double-blind study evaluated the efficacy and safety of the anti-α4β7 antibody abrilumab in patients with moderate-to-severe ulcerative colitis despite treatment with conventional therapies. METHODS: Patients (total Mayo Score 6-12, recto-sigmoidoscopy score ≥2) with inadequate response or intolerance to conventional therapies were randomized to receive subcutaneous abrilumab (7, 21, or 70 mg) on day

Metrics

Downloads

63 since deposited on 2020-01-13
Acq. date: 2025-11-12

Views

114 since deposited on 2020-01-13
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

  • Sandborn, William J
    affiliation.icon.alt
  • Cyrille, Marcoli
    affiliation.icon.alt
  • Hansen, Mark Berner
    affiliation.icon.alt
  • Feagan, Brian G
    affiliation.icon.alt
  • Loftus, Edward V
    affiliation.icon.alt
  • Rogler, Gerhard
    affiliation.icon.alt
  • Vermeire, Severine
    affiliation.icon.alt
  • Cruz, Martha L
    affiliation.icon.alt
  • Yang, Jun
    affiliation.icon.alt
  • Boedigheimer, Michael J
    affiliation.icon.alt
  • Abuqayyas, Lubna
    affiliation.icon.alt
  • Evangelista, Christine M
    affiliation.icon.alt
  • Sullivan, Barbara A
    affiliation.icon.alt
  • Reinisch, Walter
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
156

Number

Number

Number
4

Page range/Item number

Page range/Item number

Page range/Item number
946

Page end

Page end

Page end
957.e18

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2019-03

Date available

Date available

Date available
2020-01-13

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
0016-5085

OA Status

OA Status

OA Status
Hybrid

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

63 since deposited on 2020-01-13
Acq. date: 2025-11-12

Views

114 since deposited on 2020-01-13
Acq. date: 2025-11-12

Citations

Citation copied

Sandborn, W. J., Cyrille, M., Hansen, M. B., Feagan, B. G., Loftus, E. V., Rogler, G., Vermeire, S., Cruz, M. L., Yang, J., Boedigheimer, M. J., Abuqayyas, L., Evangelista, C. M., Sullivan, B. A., & Reinisch, W. (2019). Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis. Gastroenterology, 156, 946-957.e18. https://doi.org/10.1053/j.gastro.2018.11.035

Hybrid Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image